Paracetamol Aristo

Quick links

Choose a section

Quick links to important sections

Advertisements

Paracetamol Aristo

Advertisements
Advertisements

Overview of Paracetamol Aristo

What is Paracetamol Aristo? Identity, Composition, and Origin

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Pharmacological Class Analgesic, Antipyretic
Origin Synthetic Compound
Common Use Relief of pain and fever

Paracetamol Aristo is a synthetic, single-active-ingredient medicine distributed by Aristo Pharma GmbH. Its active pharmaceutical ingredient (API) is Acetaminophen, globally standardized as Paracetamol (INN). The preparation is classified as a monoseptic drug and is manufactured as a synthetic compound, ensuring purity and consistent delivery of the active agent.

This medicine is commonly available for oral administration in various dosage forms, including tablets and oral suspension. Acetaminophen is widely utilized in symptomatic care for its established therapeutic properties.


The Pharmacological Role: Analgesic and Antipyretic Classification

Paracetamol Aristo is primarily categorized as an analgesic and an antipyretic, functioning as a pain reliever and a fever reducer, respectively. This dual capability stems from its specific mechanism of action within the Central Nervous System (CNS).

Paracetamol modulates pain and fever signals by inhibiting prostaglandin synthesis within the CNS. This central action is key; it distinguishes its therapeutic profile from that of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), as Paracetamol lacks significant anti-inflammatory activity. This characteristic makes it a suitable option when the primary need is symptomatic relief of an elevated temperature or physical discomfort.


General Therapeutic Purpose and Benefit

The general therapeutic purpose of this medicine is the management of mild to moderate pain and the reduction of an elevated body temperature. By exerting its principal effects centrally, Paracetamol Aristo provides essential symptomatic relief, helping patients maintain comfort and stabilization during common illnesses without the involvement of peripheral anti-inflammatory agents.

Regulatory References

  1. Acetaminophen Information
Advertisements

What side effects are possible with Paracetamol Aristo?

Possible Side Effects and Safety Information

The safety profile of Paracetamol Aristo, based on regulatory documentation, is primarily defined by the risk of hepatotoxicity (liver damage), which is severe and dose-dependent, particularly in the event of overdose. The absolute necessity to not exceed the maximum recommended dose and to avoid concomitant use with other paracetamol-containing products is the key safety restriction.

Adverse reactions are generally rare when used correctly. The key categories of documented adverse reactions include disorders of the Immune System, Blood and Lymphatic System, and Skin.

System Organ Class Frequency Key Adverse Reactions
Skin and Subcutaneous Tissue Disorders Very Rare Serious cutaneous reactions, including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
Blood and Lymphatic System Disorders Very Rare Blood dyscrasias, such as thrombocytopenia, leucopenia, and neutropenia.
Immune System Disorders Very Rare/Not Known Anaphylaxis, hypersensitivity reactions, including skin rash and angioedema.
Hepatobiliary Disorders Dose-Related Hepatic failure (primarily associated with overdose).

Special Safety Considerations

  • Liver and Kidney Impairment: Caution is advised in patients with severe hepatic or renal impairment. The danger of liver damage from overdose is greater in individuals with non-cirrhotic alcoholic liver disease.
  • Pregnancy and Lactation: Paracetamol is considered the preferred analgesic for pain or fever during pregnancy when clinically needed, provided it is used at the lowest effective dose for the shortest possible duration. The medicine is excreted in breast milk in small amounts, and available data do not contraindicate breastfeeding when used at recommended doses.
  • Drug Interactions: Prolonged regular daily use may enhance the effect of oral anticoagulants (like warfarin), increasing the risk of bleeding. Occasional use does not pose a significant risk.
Advertisements

Overdose and Emergency Response

The official regulatory documents state that the primary risk associated with Paracetamol overdosage is the potential for severe, delayed, and irreversible liver damage, known as hepatotoxicity, which can lead to hepatic failure and death. Early symptoms of an overdose may include nausea, vomiting, pallor, anorexia, and abdominal pain; however, initial symptoms may be absent or non-specific. This silent progression necessitates a universal emergency response.

Mandatory Emergency Action

Governmental guidance mandates that patients seek immediate medical attention or referral to hospital urgently in all suspected cases of overdose. This action is explicitly required even if the patient feels well, due to the critical, time-dependent risk of serious liver injury. The emergency response protocols require the prompt measurement of the plasma Paracetamol concentration.

Treatment and Documented Outcomes

Specific life-threatening outcomes documented in regulatory texts include acute renal failure, cerebral oedema, and severe metabolic abnormalities. The specific antidote for treating Paracetamol overdose is N-acetylcysteine (NAC), which is utilized as part of the overall supportive management measures. Patients with factors leading to glutathione depletion, such as chronic alcohol use or malnutrition, are officially documented as having a greater hazard of severe overdose.

Advertisements

Therapeutic Uses of Paracetamol Aristo

Paracetamol Aristo is commonly applied in clinical settings that involve an elevated body temperature (fever), which is a symptom related to systemic imbalance. The medicine is considered relevant for easing symptoms related to physical discomfort and generalized pain signals.

The primary therapeutic benefit contributes to easing the symptom of fever and provides supportive relief for mild to moderate physical aches. It is commonly used across conditions presenting with acute episodes, helping to address common symptoms such as generalized body aches, headaches, joint discomfort, dental pain, and menstrual cramps. It is often applied during phases when symptoms become more noticeable, providing supportive assistance in scenarios where temporary symptomatic management is appropriate.

“This medicine is commonly used to help with groups of symptoms that may appear suddenly and create noticeable physiological strain.”

This supportive approach assists with easing discomfort and may contribute to maintaining functional stability when symptoms interfere with routine activities.


Quick Fact: Symptomatic Support Paracetamol Aristo is considered relevant for symptomatic relief across domains where short-term assistance for elevated temperature and acute or episodic pain is appropriate.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

The eligibility for using this medicine is determined by regulatory guidance concerning existing medical conditions, age, and concomitant medication use. Use is broadly allowed for Adults, Elderly, and Adolescents over 16 years under standard conditions [Source 1.1, 3.2].


Regulatory Contraindications (Must Not Use)

Classification Population or Condition
Absolute Contraindication Known hypersensitivity to the active substance (Paracetamol/Acetaminophen) or any excipient [Source 1.2, 3.2].
Overdose Risk Patients currently taking any other product containing paracetamol/acetaminophen [Source 1.2].
Severe Organ Disease Patients with severe hepatic impairment or severe active liver disease [Source 1.5].

Conditional Eligibility and Restrictions

Official regulatory documents advise caution and may require a reduction in dose or extended intervals for specific populations due to increased risk of toxicity [Source 1.5, 3.7]:

  • Organ Impairment: Patients with severe renal impairment or mild to moderate hepatic insufficiency (including Gilbert's syndrome) [Source 3.7].
  • Risk States: Individuals with chronic alcoholism, chronic malnutrition, sepsis, or severe hypovolemia (due to increased hazard of overdose/toxicity) [Source 1.1, 1.2].
  • Pediatric Use: The product is not recommended for children under the specific age threshold for the formulation (e.g., typically under 10 or 12 years for adult-strength tablets) [Source 3.2, 3.4].

Pregnancy and Lactation

Use is permitted if clinically needed during pregnancy and lactation. Regulatory bodies conclude that historical and extensive data indicate no proven risk of malformations or toxicity to the infant when used at the lowest effective dose for the shortest possible duration [Source 1.6, 3.1].

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Paracetamol Aristo (Acetaminophen/Paracetamol) as specified in government regulatory documents.

Drug-Drug and Drug-Substance Interactions

The co-administration of this medicine with certain substances may modify its exposure or result in documented pharmacodynamic risks. The use of any other Paracetamol-containing product is strictly contraindicated due to the severe risk of overdose and subsequent liver damage.

Interaction Type Interacting Substance(s) Official Documented Outcome
Exposure Modification Probenecid Reduces the clearance of Paracetamol, requiring a dose adjustment.
Metoclopramide, Domperidone Accelerate the rate of Paracetamol absorption.
Cholestyramine Reduces the absorption of Paracetamol, requiring intake to be separated by at least one hour.
Hepatotoxicity Risk Rifampicin, Antiepileptics (e.g., Carbamazepine) Enzyme inducers that accelerate the formation of toxic metabolites.
Chronic Alcohol Intake Potentiates the hepatotoxicity risk.
Pharmacodynamic Risk Oral Anticoagulants (e.g., Warfarin) Prolonged regular use enhances the anticoagulant effect, increasing bleeding risk.
Flucloxacillin Associated with an increased risk of high anion gap metabolic acidosis (HAGMA).
Zidovudine May increase the tendency for neutropenia.

Population-Specific Cautions

Patients with chronic alcoholism or severe renal or hepatic impairment are identified in regulatory labeling as having risk factors that heighten the danger of certain interactions, such as increased metabolic acidosis risk.

Advertisements

Mechanism of Action

Central Prostaglandin Synthesis Modulation

This domain involves the primary mechanism of Paracetamol Aristo: the selective inhibition of cyclooxygenase (COX) enzymes within the central nervous system (CNS). This activity suppresses signaling sequences that produce prostaglandins—key mediators of centrally mediated hyperthermic and nociceptive signaling. The mechanistic consequence is a shift toward diminished signaling flux within thermal and nociceptive pathways.

Endogenous Pathway Activation

Paracetamol Aristo's action engages mechanisms that influence feedback regulation within neural pathways, particularly through the generation of a bioactive metabolite, AM404. This metabolite acts on the endocannabinoid system and TRPV1 receptors centrally. This modulates key pathways associated with descending pain inhibition, which contributes to modified physiological activity characterized by reduced mediator concentration and signaling.

Serotonergic System Engagement

This drug also affects systems where specific neurotransmitters dominate, namely the descending inhibitory serotonergic pathway in the spinal cord. Paracetamol Aristo is thought to potentiate this pathway, which is relevant in cascades where multiple layers of pathway activation occur. This engagement modulates the descending inhibitory pathway, resulting in an altered signal-to-noise ratio in nociceptive transmission.

Advertisements

Dosage and Administration Information

Administration Scope: Official Guidelines

Parameter Standard Guideline
Routes Oral (tablets, suspension), Rectal (suppositories), and Intravenous (IV infusion).
Maximum Single Dose 1000 mg (1 gram).
Minimum Interval 4 hours must elapse between successive doses.
Maximum Total Daily Dose Not to exceed 4000 mg (4 grams) from all sources of the active ingredient.

Procedural and Population Rules

Standard Administration: The medicine is typically administered on an as-needed (PRN) basis every four to six hours, strictly adhering to the minimum 4-hour interval and the total daily limit. Oral forms can be taken with or without food; administration on an empty stomach may quicken the onset of the effect. Specific formulations, such as the IV solution, mandate administration only as a 15-minute infusion in a clinical setting. Extended-release tablets must be swallowed whole to preserve their release profile.

Dose Adjustments: For children and adolescents weighing less than 50 kg, dosing is weight-based, and the maximum daily limit is lowered. Furthermore, the total maximum daily dose must be significantly reduced for patients with hepatic impairment (often to 2000 mg or less). For individuals with severe renal impairment, guidelines require the dosing interval to be extended, typically to six or eight hours, to accommodate reduced clearance. A fundamental rule of use is the concurrency restriction: the medicine must never be taken with any other product containing paracetamol or acetaminophen.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Paracetamol Aristo

This section provides an objective overview of the existing clinical research related to the use of Paracetamol Aristo (or its active ingredient, paracetamol). This summary focuses strictly on the evidence structure and reported study patterns and does not offer medical advice, dosage instructions, or recommendations on treatment choice.

Evidence for Use in Acute Pain Management

Research related to the medicine's use in pain management includes numerous Randomized Controlled Trials (RCTs) and related systematic reviews that combine the findings of multiple studies. This evidence primarily was studied for outcomes related to physical discomfort observed in situations such as headaches or after dental procedures.

In these trials, researchers examined key outcomes related to physical discomfort, including how pain intensity changed over a short, defined period and the time it took for patients to report any change in symptoms. The findings describe patterns observed in the studies where pain intensity scores were measured to change during the observation period, often compared against a placebo.

Evidence for Use in Fever Reduction (Antipyresis)

The research base for fever reduction also relies on Randomized Controlled Trials and related systematic reviews. These studies were evaluated in populations experiencing an elevated body temperature, or fever, often associated with a temporary physiological imbalance.

The main outcomes related to systemic or functional imbalance that studies monitored were the degree and speed of change in body temperature measurements, alongside assessments of generalized patient comfort. Research has explored the effects in febrile children and adults, finding that temperature measurements changed within the observed time intervals.

Follow-Up and Duration of Research

The evidence available is characterized by observation periods that are short-term. The follow-up durations in the most common efficacy trials were limited, usually extending only to a few hours or, at most, a few days after administration.

Because of this focus on immediate or acute response, there is limited information for long-term outcomes and the patterns observed with repeated, continuous administration over many months or years. The research primarily contributes to understanding symptom patterns when used for temporary or episodic symptom management.

Key Studies & References Acetaminophen (Paracetamol) Drug Information Portal

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Aristo (FAQ)


Q: Is Paracetamol Aristo the same as regular paracetamol?

Paracetamol Aristo's active ingredient is Acetaminophen, which is internationally standardized as Paracetamol (INN). The terms refer to the same active substance. According to official product information, Paracetamol Aristo is simply the specific brand name for this medication.


Q: Why are people often confused about the difference between paracetamol and acetaminophen?

The confusion stems from Acetaminophen being the standardized name used in the United States and Japan, while Paracetamol is the standardized name used in most of the rest of the world for the exact same substance. Official documents and labels use these different terms based on their respective geographical area.


Q: What is the difference between Paracetamol Aristo and generic paracetamol?

Paracetamol Aristo is a brand-name medicine whose active ingredient is paracetamol. Brand-name products and generic versions are generally expected to contain the same amount of active drug. However, they may sometimes differ only in their non-active components (excipients), which are fully listed in the official package leaflet.


Q: What are the known components of Paracetamol Aristo besides the active drug?

The medicine contains the active ingredient (paracetamol/acetaminophen) and several non-active components (excipients). Official product information states that all of these inactive ingredients must be listed fully in the package leaflet or regulatory documents.


Q: Does Paracetamol Aristo treat the cause of pain or just the symptom?

According to the official therapeutic purpose, the medicine provides symptomatic relief of pain and fever. This means it modulates the signals that cause the symptoms but does not treat the underlying cause of the condition itself.


Q: What makes Paracetamol Aristo different from ibuprofen?

Regulatory documents note that this medicine is distinguished from NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) like Ibuprofen because it lacks significant anti-inflammatory activity. This difference is related to how the drug works within the body.


Q: How quickly does Paracetamol Aristo start to work?

Official information suggests that taking the medicine on an empty stomach may quicken the onset of its effect. Studies indicate that the full or maximal effect of the medicine is generally observed within about one hour after administration.


Q: Is it normal to feel no relief immediately after taking Paracetamol Aristo?

Relief is not typically immediate. The full effect is generally observed within approximately one hour after administration, according to study findings.


Q: Is the onset time faster or slower when taken with food?

Official administration rules indicate that taking the medicine with food is described as potentially delaying the onset of the effect compared to taking it on an empty stomach.


Q: Does taking Paracetamol Aristo cause drowsiness?

Official regulatory safety summaries for plain paracetamol generally do not list drowsiness as a common or frequent adverse reaction, distinguishing it from certain other classes of analgesics.


Q: Does Paracetamol Aristo have a risk of habit formation or dependence?

Regulatory agencies do not typically classify plain paracetamol as having a risk of physical dependence or habit formation when it is used at recommended doses.


Q: Does Paracetamol Aristo have a low risk of causing stomach issues?

Regulatory classification indicates the medicine is generally associated with minor gastrointestinal side effects, distinguishing it from NSAIDs which carry a greater risk, as it lacks significant anti-inflammatory activity.


Q: Does Paracetamol Aristo affect blood pressure?

In clinical settings, the intravenous (IV) administration of the active ingredient has been associated with a documented risk of a drop in blood pressure. However, this effect is not commonly observed when the medicine is taken via the oral route.


Q: Can Paracetamol Aristo be taken with common cold medicines?

Official guidance states it must not be taken with any other product containing paracetamol or acetaminophen. This is an important regulatory restriction because many cold, flu, and pain remedies contain the same active ingredient, posing a risk of exceeding the total daily limit.


Q: Is it true that Paracetamol Aristo should not be taken with alcohol?

Regulatory documents describe that chronic alcohol intake can potentiate the risk of hepatotoxicity (liver damage) associated with the medicine. Official warnings advise caution regarding use with alcohol.


Q: Can Paracetamol Aristo be taken at the same time as prescription medicines?

In official documents, the medicine is described as being compatible with many prescription medicines. However, the official leaflet must always be checked, as the regulatory agency lists specific documented interactions that must be avoided.


Q: Is Paracetamol Aristo generally considered to have high or low interaction risk?

The medicine’s interaction profile is often noted in regulatory summaries. However, several severe interactions are officially documented, such as with oral anticoagulants, and these must be avoided.


Q: Are there any known interactions with herbal supplements and Paracetamol Aristo?

Regulatory guidance notes that herbal remedies and supplements are often not officially tested for their specific effect on this medicine. Official documentation suggests that health information should be reviewed regarding combining the medicine with herbal remedies.


Q: Is it possible for Paracetamol Aristo to cause an allergic reaction?

Yes, regulatory documents list hypersensitivity reactions and anaphylaxis as documented adverse reactions, though they are classified as very rare. Any suspected reaction warrants seeking immediate medical attention.


Q: What types of allergic reactions are associated with Paracetamol Aristo?

Documented types include serious reactions such as anaphylaxis and general hypersensitivity reactions. These may involve symptoms like a skin rash, hives, and swelling of the face, throat, or tongue (angioedema).


Q: Are there any long-term effects associated with using Paracetamol Aristo?

Official research data is primarily focused on short-term use. Chronic or long-term regular use may warrant medical monitoring due to potential risks, including issues related to liver and kidney function.


Q: Does Paracetamol Aristo have a listed maximum duration of use?

US FDA labeling for over-the-counter (OTC) use generally restricts use without consulting a health professional to a maximum of 10 days for pain relief.


Q: What should be done if someone misses a time they usually take Paracetamol Aristo?

Official guidance for regular use includes the statement that a missed dose can be taken as soon as remembered. However, a strict rule applies that a patient must ensure the minimum time interval (e.g., four hours) has passed since the last dose.


Q: What does the research say about the use of Paracetamol Aristo in older patients?

Official recommendations note that paracetamol is frequently used for the elderly or frail patients. Its use is supported by long-standing safety data when taken as directed.


Q: Are there different strengths or formulations of Paracetamol Aristo available?

The active ingredient, paracetamol, is generally available in various forms, including standard tablets, oral suspensions, and suppositories. The specific strengths and product types depend on the formulation licensed for distribution in a particular region.


Q: Is Paracetamol Aristo described as a controlled substance?

No, plain paracetamol/acetaminophen is not classified as a controlled substance by major international regulatory bodies, such as the US DEA. This classification status may change, however, if the medicine is combined with other scheduled active ingredients.


Q: Does the efficacy of Paracetamol Aristo vary between different individuals?

Studies on the drug's properties have noted large variations in its bioavailability (how much is available to the body) among individuals. This variation is observed to influence the speed of onset and the overall duration of the medicine's effect.


Q: Is Paracetamol Aristo listed in the national formularies of major countries?

While Paracetamol Aristo is a specific brand, its active ingredient, paracetamol, is a widely recognized and essential medicine. It is notable that the substance is listed on the WHO List of Essential Medicines.

Advertisements

How should Paracetamol Aristo be stored and disposed of?

How to Store and Dispose of Paracetamol Aristo

Official Regulatory Requirements

Storage Scope Requirement Details
Temperature & Conditions No special storage conditions are generally required for tablets/capsules. Specific formulations must be stored below 25 C or 30 C.
Protection Store in the original packaging to maintain protection from moisture and light.
Child Safety The medicine must be kept out of the sight and reach of children.
Disposal Dispose of unused or expired product in accordance with local requirements; do not dispose in household trash or wastewater.

Summary

Official labeling defines storage primarily by ensuring the product is kept safely away from children and remains protected in its original container from environmental factors. Unused or expired medicine must be managed via established local pharmaceutical waste disposal programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Aristo found in:

A-Z Index: